Back to RXRX
KBC Group NV RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
5
Latest value
$112K
Q3 2026
Peak value
$112K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $60K |
| Q4 2025 | $50K |
| Q1 2026 | $38K |
| Q2 2026 | $45K |
| Q3 2026 | $112K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $112K | 27.2K | — | — |
| Q2 2026 | $45K | 12.3K | — | — |
| Q1 2026 | $38K | 12.3K | — | — |
| Q4 2025 | $50K | 12.3K | — | — |
| Q3 2025 | $60K | 12.3K | — | — |